Exploration of association differences across multiple sub-phenotypes of Crohn’s disease and ulcerative colitis
Study code
DAA068
Lead researcher
Dr Christopher Larminie
Study type
Data only
Institution or company
GlaxoSmithKline
Researcher type
Commercial
Speciality area
Gastroenterology
Recruitment Site
N/A (data only)
Summary
There are approximately 500,000 patients living with ulcerative colitis and Crohn’s disease in the UK. The severity of disease can range from mild to severe, but many patients have chronic debilitating symptoms which can be recurring and difficult to manage. The researchers of this project will look at clinical data (for example: age at diagnosis; type, and severity of disease; comparing individuals with Crohn’s disease who either have or do not have a fistula etc) and genetic variation in 7 genes across these patient groups. The aim of the study is to not only learn more about how these conditions develop and behave but also to see if these genes can be targeted to develop new drug interventions.
Patient benefit
There is substantial unmet need within Crohn's Disease and Ulcerative colitis. The proposed analyses may assist in confidence around select targets, which may ultimately translate into therapies for patients with most unmet need.